29.80 USD
↘ 0.15 (0.49%)LIVE (AS OF 02:40 PM EDT)
Viking Therapeutics, Inc
VKTXNASDAQ • USD
Market: OPEN
Shares of Viking Therapeutics, Inc (VKTX) are trading at $29.80. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Sep 15, 2026.
Open?$30.02
High?$30.76
Low?$29.77
Prev. Close?$29.95
Volume?1.6M
Avg. Volume?1.8M
VWAP?$30.20
Rel. Volume?0.92x
Bid / Ask
Bid?$29.93 × 100
Ask?$29.98 × 100
Spread?$0.05
Midpoint?$29.96
Valuation & Ratios
Market Cap?3.5B
Shares Out?116.7M
Float?112.1M
Float %?96.1%
P/E Ratio?N/A
P/B Ratio?8.56
EPS?-$4.58
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Employees
65
Market Cap
3.5B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-04-29
Address
9920 PACIFIC HEIGHTS BLVD, SUITE 500
SAN DIEGO, CA
Phone: 858-704-4660
SAN DIEGO, CA
Phone: 858-704-4660
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?39
Piotroski F-Score?0/9Weak
Altman Z-Score?12.81Safe
Confidence?52%Low
Short InterestVery High
Short % of Float?19.80%High
Short Interest?22.2M
Days to Cover?12.4
Free Float112.1M
Avg Daily Volume1.8M
Settlement Date2026-08-31
Financial Health
Current Ratio?4.72Strong
Quick Ratio?4.72Strong
Cash Ratio?1.15Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 3 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?8.56HIGH▾
Peers75
S&P22
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-6.0CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-131.0%WEAK▾
Peers33
S&P3
ROA?-102.5%WEAK▾
Peers33
S&P3
Cash Flow & Enterprise
FCF?$-418441000
Enterprise Value?$3.4B
Fundamentals ratios updated end of day